About ACCESS BIO, INC.
Access Bio is a global leader in the development and commercialization of in vitro diagnostic technologies, focusing on infectious disease diagnosis, including malaria, HIV, HPV, and COVID-19. The company provides a wide range of diagnostic tests, analyzers, and molecular diagnostic products.
Development and commercialization of in vitro diagnostic testsProduction of rapid diagnostic tests for infectious diseases (e.g., malaria, dengue, HIV, syphilis)Manufacturing of molecular diagnostic tests (e.g., RT-PCR, genotyping)Development of biosensor and analyzer technologiesSupply of diagnostic solutions for global health challenges
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| Federal contract award | Department of Defense | $205.2M | |
| OVER THE COUNTER (OTC) COVID-19 TESTS | Department of Health and Human Services | $88.7M | |
| Federal contract award | Department of Health and Human Services | $46.8M |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ACCESS BIO, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.